scholarly journals Wrapping glia regulates neuronal signaling speed and precision in the peripheral nervous system of Drosophila

2020 ◽  
Vol 11 (1) ◽  
Author(s):  
Rita Kottmeier ◽  
Jonas Bittern ◽  
Andreas Schoofs ◽  
Frederieke Scheiwe ◽  
Till Matzat ◽  
...  

Abstract The functionality of the nervous system requires transmission of information along axons with high speed and precision. Conductance velocity depends on axonal diameter whereas signaling precision requires a block of electrical crosstalk between axons, known as ephaptic coupling. Here, we use the peripheral nervous system of Drosophila larvae to determine how glia regulates axonal properties. We show that wrapping glial differentiation depends on gap junctions and FGF-signaling. Abnormal glial differentiation affects axonal diameter and conductance velocity and causes mild behavioral phenotypes that can be rescued by a sphingosine-rich diet. Ablation of wrapping glia does not further impair axonal diameter and conductance velocity but causes a prominent locomotion phenotype that cannot be rescued by sphingosine. Moreover, optogenetically evoked locomotor patterns do not depend on conductance speed but require the presence of wrapping glial processes. In conclusion, our data indicate that wrapping glia modulates both speed and precision of neuronal signaling.

2014 ◽  
Author(s):  
◽  
Jeffrey Dale

[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] The efficiency of signal propagation in the peripheral nervous system (PNS) is maximized by myelination and axon diameter. Myelination induces axonal expansion through radial growth. Radial growth is dependent on neurofilaments (NFs) that can be made up of the neurofilament light (NF-L) subunit in association with either the neurofilament medium (NF-M) or neurofilament heavy (NF-H) subunit. Myelin thickness and length (internodal) are established proportional to axon diameter for optimal conduction velocity. Myelin thickness is regulated by total neuregulin I type III (Nrg1 type III) levels present on the axon whereas the mechanisms that control the establishment of internodal length are less understood. My work expands on previous data demonstrating that myelin thickness does not respond to alterations in axonal diameter. In contrast to the previous study, my work describes myelin thickness in the context of decreased axonal diameters. NF subunit mutants that result in varying degrees of altered axonal diameter were used as a tool to study the response of myelin thickness to larger reductions in axonal diameter. At two and six months, g-ratios corresponded to the degree of axonal diameter change. At two months, the size of axons arranged into the following order: wild type > NF-H[superscript [[delta]]Tail] > NF-M[superscript [[delta]]Tail]>NF-(M/H) [superscript [[delta]]Tail]. Correspondingly, g-ratios arranged into the same order indicating the larger the decrease in axon diameter, the greater the proportional increase in myelin thickness. At six months, axon diameters grouped into "wild type" sizes and "NFM?Tail" sizes. Similarly, g-ratios grouped into "wild type" ratios and "NF-M?Tail" ratios indicating that myelin thickness did not respond to increased radial growth. At six months NF-M?Tail mice demonstrated decreased internodal length suggesting that internodal length responded to alterations in axon diameter. My work provides the first evidence of the consequence of altered myelin thickness in isolation. Mice with hypomyelination, alone, demonstrated reduced swing speed and stride length in all limbs. Mutations in proteins specific to myelin result CMT1 that display uniform slowing of conduction velocity. In contrast, CMT2E arises from mutations to axonal proteins resulting in non-uniform slowing of conduction velocity. We generated a mouse model of CMT2E by expressing a hNF-L[superscript E397K] transgene. hNF-L[superscript E397K] expression causes inherent defects to the neurofilament network. As a result, our CMT2E model demonstrates altered myelin thickness in motor and sensory nerves and unilateral gait alterations that include decreased stride length, increased foot drags, and altered coordination of coupled limbs. The correlation between defects observed in our hypomyelination model and our CMT2E model suggest that altered myelin thickness may play a role in CMT2E phenotype. NF accumulations first appear at the NMJs of the diaphragm in SMA?7 mice. Motor axon loss and decreased axonal diameter is observed in the cervical spinal cord which is responsible for innervating the diaphragm. Taken together, these data suggest that inherent NF defects may be present in SMA?7 mice. My work provides a comprehensive analysis of the NF network in a cell, sciatic nerve, where analyses wouldn't be confounded by axonal loss. My analyses demonstrated that total NF levels, trafficking, and deposition were unaffected in SMA?7 mice suggesting that the NF network was uncompromised. Therefore, NF accumulations at the NMJ are most likely due to local alterations to NF dynamics. Furthermore, my work demonstrates that alterations to the transport of retrograde motors and anterograde transport of vital synaptic vesicle proteins coincide with the appearance of NF accumulations.


Author(s):  
S.S. Spicer ◽  
B.A. Schulte

Generation of monoclonal antibodies (MAbs) against tissue antigens has yielded several (VC1.1, HNK- 1, L2, 4F4 and anti-leu 7) which recognize the unique sugar epitope, glucuronyl 3-sulfate (Glc A3- SO4). In the central nervous system, these MAbs have demonstrated Glc A3-SO4 at the surface of neurons in the cerebral cortex, the cerebellum, the retina and other widespread regions of the brain.Here we describe the distribution of Glc A3-SO4 in the peripheral nervous system as determined by immunostaining with a MAb (VC 1.1) developed against antigen in the cat visual cortex. Outside the central nervous system, immunoreactivity was observed only in peripheral terminals of selected sensory nerves conducting transduction signals for touch, hearing, balance and taste. On the glassy membrane of the sinus hair in murine nasal skin, just deep to the ringwurt, VC 1.1 delineated an intensely stained, plaque-like area (Fig. 1). This previously unrecognized structure of the nasal vibrissae presumably serves as a tactile end organ and to our knowledge is not demonstrable by means other than its selective immunopositivity with VC1.1 and its appearance as a densely fibrillar area in H&E stained sections.


2000 ◽  
Vol 5 (2) ◽  
pp. 3-3
Author(s):  
Christopher R. Brigham ◽  
James B. Talmage

Abstract Lesions of the peripheral nervous system (PNS), whether due to injury or illness, commonly result in residual symptoms and signs and, hence, permanent impairment. The AMA Guides to the Evaluation of Permanent Impairment (AMA Guides) describes procedures for rating upper extremity neural deficits in Chapter 3, The Musculoskeletal System, section 3.1k; Chapter 4, The Nervous System, section 4.4 provides additional information and an example. The AMA Guides also divides PNS deficits into sensory and motor and includes pain within the former. The impairment estimates take into account typical manifestations such as limited motion, atrophy, and reflex, trophic, and vasomotor deficits. Lesions of the peripheral nervous system may result in diminished sensation (anesthesia or hypesthesia), abnormal sensation (dysesthesia or paresthesia), or increased sensation (hyperesthesia). Lesions of motor nerves can result in weakness or paralysis of the muscles innervated. Spinal nerve deficits are identified by sensory loss or pain in the dermatome or weakness in the myotome supplied. The steps in estimating brachial plexus impairment are similar to those for spinal and peripheral nerves. Evaluators should take care not to rate the same impairment twice, eg, rating weakness resulting from a peripheral nerve injury and the joss of joint motion due to that weakness.


2004 ◽  
Author(s):  
G. Galietta ◽  
A. Capasso ◽  
A. Fortuna ◽  
F. Fabi ◽  
P. Del Basso ◽  
...  

2019 ◽  
Vol 1 (2) ◽  
pp. 11-14
Author(s):  
O. S. Levin ◽  
O. V. Matvievskaya

The article contains a comprehensive analysis of the summary epidemiological data obtained during the observational study to assess the effect of therapy with Ipigrix® on the dynamics of motor and sensory functions, as well as the severity of pain in outpatient patients with various diseases of the peripheral nervous system: mononeuropathy, polyneuropathy and polyradiculopathy of various origins.


Sign in / Sign up

Export Citation Format

Share Document